Cancer Control in New York
Cancer Control (93.399) awarded $62.0 million to recipients in New York in 10 grants from fiscal 2021 to 2025, 7.6% of the program's national total. University of Rochester received the most, $29.8 million.
- Awarded in New York$62.0 million
- Awards10
- Share of the program7.6%
- Rank among states3rd of 37
- National total$814 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 6 | $11.1 million |
| FY 2022 | 7 | $11.4 million |
| FY 2023 | 6 | $11.6 million |
| FY 2024 | 9 | $14.2 million |
| FY 2025 | 9 | $13.8 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Rochester | Colleges and universities | 1 | $29.8 million |
| Weill Medical College of Cornell University | Colleges and universities | 2 | $9.4 million |
| The Feinstein Institutes for Medical Research | Nonprofits | 1 | $6.1 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 1 | $5.0 million |
| New York University | Colleges and universities | 2 | $4.3 million |
| Montefiore Medical Center | Nonprofits | 1 | $4.2 million |
| Sloan-Kettering Institute for Cancer Research | Nonprofits | 2 | $3.1 million |
Open opportunities under this program
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
See all 52 on the program page
Questions people ask
How much Cancer Control money goes to New York?
$62.0 million from fiscal 2021 to 2025, across 10 awards. New York ranks 3rd of 37 states and territories for this program.
Who receives Cancer Control money in New York?
The largest recipient is University of Rochester, with $29.8 million in 1 award. Next are Weill Medical College of Cornell University and The Feinstein Institutes for Medical Research.
Can organizations in New York apply now?
Yes, 52 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Control in other states
- Pennsylvania
- Illinois
- California
- Wisconsin
- Michigan
- Washington
- North Carolina
- Oregon
- South Carolina
- Minnesota
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund